Cresemba and Abdominal pain upper - a phase IV clinical study of FDA data

Summary:

Abdominal pain upper is reported as a side effect among people who take Cresemba (isavuconazonium sulfate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Oxycodone, and have Nausea.

The phase IV clinical study analyzes which people have Abdominal pain upper when taking Cresemba. It is created by eHealthMe based on reports of 2,573 people who have side effects when taking Cresemba from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

What is Abdominal pain upper?

Abdominal pain upper is found to be associated with 2,963 drugs and 4,497 conditions by eHealthMe. Check the latest studies of Abdominal pain upper.

On Aug, 10, 2026

2,573 people reported to have side effects when taking Cresemba.
Among them, 14 people (0.54%) have Abdominal pain upper.

Could Cresemba cause Abdominal pain upper?

Among these 14 people:

How long have people been on Cresemba when they have Abdominal pain upper? *

What is the gender of people who have Abdominal pain upper when taking Cresemba? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Abdominal pain upper when taking Cresemba? *

What are other drugs people take besides Cresemba? *

What are other side effects people have besides Abdominal pain upper? *

Abdominal Distension: 5 people, 35.71%
Constipation: 4 people, 28.57%
Fever: 4 people, 28.57%
Diarrhea: 3 people, 21.43%
Nausea And Vomiting: 3 people, 21.43%
Back Pain: 3 people, 21.43%
Crying: 2 people, 14.29%
Headache (pain in head): 2 people, 14.29%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 14.29%
Liver Disorder (liver diseases): 2 people, 14.29%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 3 people, 21.43%
Pneumonia: 2 people, 14.29%
Pain: 2 people, 14.29%
Nocardia Infection (a bacterial infection that usually starts in the lungs. it may spread to other organ systems): 2 people, 14.29%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 2 people, 14.29%
Headache (pain in head): 2 people, 14.29%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 14.29%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.14%
Dyspnea (difficult or laboured breathing): 1 person, 7.14%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cresemba and have Abdominal pain upper?

- Check whether Abdominal pain upper is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cresemba:

Cresemba (2,574 reports)

Browse all side effects of Cresemba:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain upper:

Abdominal pain upper (2,963 drugs)

Browse all the conditions that are associated with Abdominal pain upper:

Abdominal pain upper (4,497 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isavuconazonium sulfate (the active ingredients of Cresemba) and Cresemba (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.